Neurogenic orthostatic hypotension in Parkinson's disease: is there a role for locus coeruleus magnetic resonance imaging?

被引:1
|
作者
Palermo, Giovanni [1 ]
Galgani, Alessandro [2 ]
Bellini, Gabriele [1 ]
Lombardo, Francesco [3 ]
Martini, Nicola [4 ]
Morganti, Riccardo [5 ]
Paoli, Davide [1 ]
De Cori, Sara [3 ]
Frijia, Francesca [4 ,6 ]
Siciliano, Gabriele [1 ]
Ceravolo, Roberto [1 ]
Giorgi, Filippo Sean [2 ]
机构
[1] Univ Pisa, Ctr Neurodegenerat Dis Parkinsons Dis & Movement D, Dept Clin & Expt Med, Unit Neurol, Pisa, Italy
[2] Univ Pisa, Dept Translat Res & New Surg & Med Technol, Pisa, Italy
[3] Fdn Monasterio, CNR, Dept Radiol, Pisa, Italy
[4] Fdn Monasterio, CNR, Deep Hlth Unit, Pisa, Italy
[5] Univ Pisa, Sect Stat, Pisa, Italy
[6] Fdn Monasterio, CNR, Bioengn Unit, Pisa, Italy
关键词
Dysautonomia; Locus coeruleus; Magnetic resonance imaging; Orthostatic hypotension; Parkinson's disease; CLINICAL DIAGNOSTIC-CRITERIA; COERULEUS/SUBCOERULEUS COMPLEX; SUBSTANTIA-NIGRA; SYSTEM; NEUROPATHOLOGY; DYSFUNCTION; PROGRESSION; DISORDERS; PATHOLOGY; DEMENTIA;
D O I
10.1007/s00702-023-02721-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Locus coeruleus (LC) is the main noradrenergic nucleus of the brain, and degenerates early in Parkinson's disease (PD). The objective of this study is to test whether degeneration of the LC is associated with orthostatic hypotension (OH) in PD. A total of 22 cognitively intact PD patients and 52 age-matched healthy volunteers underwent 3 T magnetic resonance (MRI) with neuromelanin-sensitive T1-weighted sequences (LC-MRI). For each subject, a template space-based LC-MRI was used to calculate LC signal intensity (LC contrast ratio-LCCR) and the estimated number of voxels (LCVOX) belonging to LC. Then, we compared the LC-MRI parameters in PD patients with OH (PDOH+) versus without OH (PDOH-) (matched for sex, age, and disease duration) using one-way analysis of variance followed by multiple comparison tests. We also tested for correlations between subject's LC-MRI features and orthostatic drop in systolic blood pressure (SBP). PDOH- and PDOH+ did not differ significantly (p > 0.05) based on demographics and clinical characteristics, except for blood pressure measurements and SCOPA-AUT cardiovascular domain (p < 0.05). LCCR and LCVOX measures were significantly lower in PD compared to HC, while no differences were observed between PDOH- and PDOH+. Additionally, no correlation was found between the LC-MRI parameters and the orthostatic drop in SBP or the clinical severity of autonomic symptoms (p > 0.05). Conversely, RBD symptom severity negatively correlated with several LC-MRI parameters. Our results failed to indicate a link between the LC-MRI features and the presence of OH in PD but confirmed a marked alteration of LC signal in PD patients.
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [41] Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson's Disease (NOH306A)
    Hauser, Robert A.
    Hewitt, L. Arthur
    Isaacson, Stuart
    JOURNAL OF PARKINSONS DISEASE, 2014, 4 (01) : 57 - 65
  • [42] Neurogenic Orthostatic Hypotension in Parkinson's disease: Does it matter if "asymptomatic" or associated with supine hypertension?
    Merola, A.
    Romagnolo, A.
    Rosso, M.
    Castellanos, R. L.
    Wissel, B. D.
    Larkin, S.
    Bernardini, A.
    Zibetti, M.
    Lopiano, L.
    Espay, A. J.
    MOVEMENT DISORDERS, 2016, 31 (09) : E10 - E10
  • [43] Fall-related healthcare use and costs in neurogenic orthostatic hypotension with Parkinson's disease
    Francois, Clement
    Biaggioni, Italo
    Shibao, Cyndya
    Ogbonnaya, Augustina
    Shih, Huai-Che
    Farrelly, Eileen
    Ziemann, Adam
    Duhig, Amy
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (05) : 525 - 532
  • [44] Impact of neurogenic orthostatic hypotension on healthcare utilization and costs associated with falls in Parkinson's disease
    Francois, C.
    Biaggioni, I.
    Shibao, C. A.
    Ogbonnaya, A.
    Shih, H. -C.
    Farrelly, E.
    Ziemann, A.
    Duhig, A.
    MOVEMENT DISORDERS, 2016, 31 : S147 - S147
  • [45] Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson's disease
    Imbalzano, Gabriele
    Ledda, Claudia
    Tangari, Marta Maria
    Artusi, Carlo Alberto
    Montanaro, Elisa
    Rizzone, Mario Giorgio
    Zibetti, Maurizio
    Lopiano, Leonardo
    Romagnolo, Alberto
    CLINICAL AUTONOMIC RESEARCH, 2024, 34 (06) : 593 - 601
  • [46] Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases
    Alessandro Galgani
    Francesco Lombardo
    Daniele Della Latta
    Nicola Martini
    Ubaldo Bonuccelli
    Francesco Fornai
    Filippo Sean Giorgi
    Current Neurology and Neuroscience Reports, 2021, 21
  • [47] Locus Coeruleus Magnetic Resonance Imaging in Neurological Diseases
    Galgani, Alessandro
    Lombardo, Francesco
    Della Latta, Daniele
    Martini, Nicola
    Bonuccelli, Ubaldo
    Fornai, Francesco
    Giorgi, Filippo Sean
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2021, 21 (01)
  • [48] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
    Daniel Kremens
    Mark Lew
    Daniel Claassen
    Brent P. Goodman
    Clinical Autonomic Research, 2017, 27 : 29 - 31
  • [49] Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension
    Hauser, Robert A.
    Heritier, Stephane
    Rowse, Gerald J.
    Hewitt, L. Arthur
    Isaacson, Stuart H.
    CLINICAL NEUROPHARMACOLOGY, 2016, 39 (05) : 220 - 226
  • [50] Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
    Hauser, Robert A.
    Biaggioni, Italo
    Hewitt, L. Arthur
    Vernino, Steven
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2018, 5 (06): : 627 - 634